Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China
· Delayed Price · Currency is CNY 17.58
+0.42 (2.45%)
Jul 14, 2025, 2:45 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 7.10 billion as of July 14, 2025. Its market cap has increased by 74.90% in one year.
Market Cap
7.10B
Enterprise Value
7.28B
Revenue
605.55M
Ranking
n/a
PE Ratio
178.91
Stock Price
17.58
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 7.10B, a decrease of -56.07%. That is a compound annual growth rate of -18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 6.97B | 61.89% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 379.76B |
| Shenzhen Mindray Bio-Medical Electronics | 267.37B |
| WuXi AppTec | 221.10B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.46B |
| Aier Eye Hospital Group | 116.29B |
| Sichuan Biokin Pharmaceutical | 112.78B |
| Shanghai United Imaging Healthcare | 102.91B |
| Yunnan Baiyao Group Co.,Ltd | 100.04B |